Massive peripapillary subretinal neovascularization: An indication for submacular surgery

Retina

Volumn 24, Issue 2, 2004, Pages 219-225

  Kertes, Peter J ^a,b  

^a UNIVERSITY OF OTTAWA EYE INSTITUTE   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Choroidal neovascularization; Ocular histoplasmosis syndrome; Peripapillary choroidal neovascularization; Peripapillary subretinal neovascularization; Submacular surgery; Subretinal neovascularization

Indexed keywords

ADULT; ARGON LASER; ARTICLE; CASE REPORT; CATARACT; FEMALE; FOLLOW UP; HUMAN; OCULAR HISTOPLASMOSIS; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; RETINA DETACHMENT; RETINOPEXY; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

ADULT; EYE INFECTIONS, FUNGAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HISTOPLASMOSIS; HUMANS; MACULA LUTEA; OPHTHALMOLOGIC SURGICAL PROCEDURES; RETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 1942477659     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200404000-00005     Document Type: Article

References (22)

1. Lopez PF, Green WR. Peripapillary subretinal neovascularization. Retina 1992;12:147-171.
2. Flaxel CJ, Bird AC, Hamilton AMP, et al. Partial laser ablation of massive peripapillary subretinal neovascularization. Ophthalmology 1996;103:1250-1259.
3. Macular Photocoagulation Study Group. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Arch Ophthalmol 1994;112:462-464.
4. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial. Arch Ophthalmol 1987;105(11):1499-1507.
5. Macular Photocoagulation Study Group. Laser photocoagulation for neovascular lesions nasal to the fovea: results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes. Arch Ophthalmol 1995;113:56-61.
6. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP Report 1. Arch Ophthalmol 1999;117:1329-1345.
7. Saperstein DA, Rosenfeld PJ, Bressler NM, et al. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series. Ophthalmology 2002;109:1499-1505.
8. Busquets MA, Shah GK, Wickens J, et al. Ocular photodynamic therapy with verteporfin for choroidal neovascularization secondary to ocular histoplasmosis syndrome. Retina 2003;23:299-306.
9. deJuan E, Machemer R. Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol 1988;105:25-29.
10. Thomas M, Kaplan H. Surgical removal of subfoveal neovascularization in the presumed ocular histoplasmosis syndrome. Am J Ophthalmol 1991;111:1-7.
11. Submacular Surgery Trials Pilot Study Investigators. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic outcomes. Am J Ophthalmol 2000;130:387-407.
12. Rao PK, Thomas MA. Update on surgical removal of choroidal neovascularization. Curr Opin Ophthalmol 2000;11:180-185.
13. Stone TW, Sternberg P Jr. Submacular surgery trials update. Ophthalmol Clin North Am 2002;15:479-488.
14. Grossniklaus HE, Green WR. Histopathologic and ultrastructural findings of surgically excised choroidal neovascularization. Submacular Surgery Trials Research Group. Arch Ophthalmol 1998;116:745-749.
15. Roth DB, Downie AA, Charles ST. Visual results after submacular surgery for neovascularization in age-related macular degeneration. Ophthalmic Surg Lasers 1997;18(11):920-925.
16. Atebara NH, Thomas MA, Holekamp NM, et al. Surgical removal of extensive peripapillary choroidal neovascularization associated with the presumed ocular histoplasmosis syndrome. Ophthalmology 1998;105:1598-1605.
17. Gass JDM. Pathophysiologic and histopathologic bases for interpretation of fluorescein angiography. In: Gass JDM. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. 4th ed. St. Louis: Mosby-Year Book; 1997:2-49.
18. Grossniklaus HE, Gass JD. Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes. Am J Ophthalmol 1998;126:127-129.
19. Joseph DP, Thomas MA. Present indications for removal of choroidal neovascular membranes. Curr Opin Ophthalmol 1998;9:23-30.
20. Fuji GY, de Juan E Jr, Pieramici DJ, et al. Inferior limited macular translocation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: 1-year visual outcome and recurrence report. Am J Ophthalmol 2002;134:69-74.
21. Pieramici DJ, de Juan E Jr, Fujii GY, et al. Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol 2000;130:419-428.
22. American Academy of Ophthalmology. Macular translocation. Ophthalmology 2000;107:1015-1018.